HomeCompareCTPCF vs PFE

CTPCF vs PFE: Dividend Comparison 2026

CTPCF yields 5.48% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTPCF wins by $3.54M in total portfolio value
10 years
CTPCF
CTPCF
● Live price
5.48%
Share price
$1.43
Annual div
$0.08
5Y div CAGR
58.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.59M
Annual income
$2,645,548.16
Full CTPCF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CTPCF vs PFE

📍 CTPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTPCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTPCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTPCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTPCF
Annual income on $10K today (after 15% tax)
$466.07/yr
After 10yr DRIP, annual income (after tax)
$2,248,715.94/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, CTPCF beats the other by $2,226,396.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTPCF + PFE for your $10,000?

CTPCF: 50%PFE: 50%
100% PFE50/50100% CTPCF
Portfolio after 10yr
$1.82M
Annual income
$1,335,903.44/yr
Blended yield
73.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CTPCF
No analyst data
Altman Z
-0.3
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTPCF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTPCFPFE
Forward yield5.48%6.13%
Annual dividend / share$0.08$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR58.5%13.2%
Portfolio after 10y$3.59M$49.6K
Annual income after 10y$2,645,548.16$26,258.71
Total dividends collected$3.48M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTPCF vs PFE ($10,000, DRIP)

YearCTPCF PortfolioCTPCF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,569$869.07$9,153$693.39+$2.4KCTPCF
2$13,868$1,489.36$8,593$849.25+$5.3KCTPCF
3$17,484$2,644.66$8,336$1,066.78+$9.1KCTPCF
4$23,646$4,938.87$8,437$1,384.80+$15.2KCTPCF
5$35,196$9,894.75$9,013$1,875.40+$26.2KCTPCF
6$59,477$21,816.41$10,306$2,680.72+$49.2KCTPCF
7$118,250$54,610.49$12,820$4,101.38+$105.4KCTPCF
8$287,362$160,834.12$17,673$6,826.70+$269.7KCTPCF
9$886,440$578,962.44$27,543$12,591.86+$858.9KCTPCF
10$3,594,039$2,645,548.16$49,560$26,258.71+$3.54MCTPCF

CTPCF vs PFE: Complete Analysis 2026

CTPCFStock

CITIC Limited operates in the financial services, resources and energy, manufacturing, engineering contracting, advanced materials, consumption, and urbanization businesses worldwide. The company's Comprehensive Financial Services segment provides banking, trust, insurance and reinsurance, investment banking, wealth and asset management, financial markets, equity investment, financing, and other integrated financial services. Its Advanced Intelligent Manufacturing segment offers wheels and lightweight cast components, and chassis and body systems; and mining and heavy machinery, specialized robots and intelligent equipment, new energy equipment, and special materials. The company's Advanced Materials segment offers special steel products; and high-grade chloride, as well as explores, develops, and produces oil. It also invests in coal and bauxite mining, import and export of commodities, electrolytic aluminum, and alumina smelting; and invests in and manages power plants. The company's New Consumption segment provides telecommunications services; and leases and sells satellite transponders. It also publishes books and digital books, as well as engages in bookstore retailing business. In addition, this segment deals and distributes with supporting services for automotive brands; and develops agricultural science and technology, as well as engages in the brand development, manufacturing, commodity trading, agency distribution, logistics, and retail in the food and fast-moving consumer goods, healthcare, and electrical products industries. The company's New-Type Urbanisation segment provides environmental and infrastructure, contracting and design, healthcare, and general aviation services; and develops and invests in mixed-use and commercial properties, and residential properties. The company was formerly known as CITIC Pacific Limited and changed its name to CITIC Limited in August 2014. The company was founded in 1987 and is based in Central, Hong Kong.

Full CTPCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CTPCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTPCF vs SCHDCTPCF vs JEPICTPCF vs OCTPCF vs KOCTPCF vs MAINCTPCF vs JNJCTPCF vs MRKCTPCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.